Skip to Main Content

News Center

SOP Hosts Inaugural John W. Holaday Endowed Memorial Lecture in Medical Cannabis

October 8, 2020

Keynote speaker Dr. Raphael Mechoulam discusses his decades-long career as one of the world’s pre-eminent cannabis scientists and shares his hopes for the future of the field.

The PATIENTS Program Hosts First-Ever Community Research Jam

October 7, 2020

Inaugural event helps amplify the community’s voice and demonstrates the value of early engagement in research.

SOP’s Heil Speaks to Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

October 6, 2020

Two-day virtual meeting brought together stakeholders from academia, government, and industry to discuss challenges related to antimicrobial stewardship during the COVID-19 pandemic.

SOP Hosts Inaugural John W. Holaday Endowed Memorial Lecture in Medical Cannabis

October 8, 2020

Keynote speaker Dr. Raphael Mechoulam discusses his decades-long career as one of the world’s pre-eminent cannabis scientists and shares his hopes for the future of the field.

The PATIENTS Program Hosts First-Ever Community Research Jam

October 7, 2020

Inaugural event helps amplify the community’s voice and demonstrates the value of early engagement in research.

SOP’s Heil Speaks to Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria

October 6, 2020

Two-day virtual meeting brought together stakeholders from academia, government, and industry to discuss challenges related to antimicrobial stewardship during the COVID-19 pandemic.

Grant Increases Access, Safety of Generic Drugs

September 29, 2020

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

M-CERSI Workshop Spotlights 3D Cell Culture Models for Drug PK, Safety, and Efficacy Assessment

September 22, 2020

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

SOP Researchers Make Progress Toward Antiviral Treatments for COVID-19

September 16, 2020

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

School Forms Diversity, Equity, and Inclusion Task Force

September 15, 2020

The dean of the University of Maryland School of Pharmacy has formed a Diversity, Equity, and Inclusion (DEI) Task Force to guide the development of concrete plans to ensure that the School is welcoming, inclusive, and representative of everyone in its community.